Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 15Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3CRESCITA THERAP

02 8SCILEX PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LIDOCAINE

US Patent Number : 9925264

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207962

Patent Use Code : U-2267

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-05-10

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LIDOCAINE

US Patent Number : 11786455

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207962

Patent Use Code : U-2267

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-05-10

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LIDOCAINE

US Patent Number : 11793766

Drug Substance Claim :

Drug Product Claim :

Application Number : 207962

Patent Use Code : U-2267

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-05-10

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LIDOCAINE

US Patent Number : 9283174

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207962

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-05-10

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LIDOCAINE

US Patent Number : 10765749

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207962

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-05-10

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LIDOCAINE

US Patent Number : 9931403

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207962

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-05-10

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LIDOCAINE

US Patent Number : 11278623

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207962

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-05-10

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LIDOCAINE

US Patent Number : 10765640

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207962

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-05-10

blank

09

CRESCITA THERAP

arrow
Antibody Engineering
Not Confirmed

CRESCITA THERAP

Country
arrow
Antibody Engineering
Not Confirmed

LIDOCAINE; TETRACAINE

US Patent Number : 10603293

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21717

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-01-14

blank

10

CRESCITA THERAP

arrow
Antibody Engineering
Not Confirmed

CRESCITA THERAP

Country
arrow
Antibody Engineering
Not Confirmed

LIDOCAINE; TETRACAINE

US Patent Number : 10751305

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21717

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-01-14

blank